Regorafenib (BAY 73-4506) Clinical Trials
5 recruitingDrug
Phase 24Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
Fudan University350 enrolled1 locationNCT07328009
Recruiting
Phase 1
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Zhejiang University72 enrolled2 locationsNCT05155189
Recruiting
Phase 2
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
The Methodist Hospital Research Institute57 enrolled1 locationNCT06887218
Recruiting
Phase 2
Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes
Sergey Orlov, MD60 enrolled1 locationNCT06949982
Recruiting
Phase 2
"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
MCRC
Beijing Friendship Hospital52 enrolled1 locationNCT06829355